Candriam Equities L Biotech.I EUR Acc/ LU1120766032 /
| NAV02/05/2024 | Diferencia+64.6099 | Tipo de beneficio | Enfoque de la inversión | Sociedad de fondos |
|---|---|---|---|---|
| 2,188.1899EUR | +3.04% | reinvestment | Equity Worldwide | Candriam ▶ |
Rendimiento mensual
| ene. | feb. | mar. | abr. | may. | jun. | jul. | ago. | sep. | oct. | nov. | dic. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 | - | - | - | - | - | - | - | - | -11.00 | 9.00 | 8.02 | -2.36 | - |
| 2016 | -22.88 | -4.93 | -1.29 | 3.06 | 8.39 | -8.04 | 11.86 | -2.02 | 2.94 | -10.16 | 12.33 | -2.27 | -17.28% |
| 2017 | 2.99 | 8.66 | -0.73 | -0.63 | -6.06 | 7.75 | -0.77 | 5.59 | 1.39 | -4.99 | -2.01 | 0.83 | +11.43% |
| 2018 | 2.97 | -2.64 | -2.70 | -1.36 | 8.35 | 0.97 | 4.46 | 4.80 | -1.85 | -11.78 | 4.28 | -9.24 | -5.57% |
| 2019 | 12.84 | 4.24 | 0.92 | -4.67 | -4.18 | 7.07 | -0.09 | -1.27 | -3.22 | 7.98 | 13.15 | 0.65 | +36.28% |
| 2020 | -3.94 | -0.26 | -4.88 | 13.11 | 7.67 | 0.44 | -7.71 | -0.21 | 2.72 | -2.15 | 6.96 | 0.76 | +11.20% |
| 2021 | 2.61 | -2.43 | -1.06 | 0.36 | -3.34 | 9.33 | -1.38 | 4.46 | -2.39 | 0.38 | -1.61 | 1.44 | +5.86% |
| 2022 | -9.49 | -2.17 | 6.73 | -2.56 | -4.79 | 5.58 | 7.26 | 2.53 | 0.67 | 6.00 | 1.92 | -6.17 | +3.88% |
| 2023 | 1.21 | -3.40 | -1.97 | 0.66 | 2.31 | -1.05 | -1.18 | 1.42 | -1.89 | -5.97 | 2.68 | 12.11 | +3.96% |
| 2024 | 3.05 | 1.74 | 0.26 | -5.18 | 3.04 | - | - | - | - | - | - | - | - |
Valores estimados
| Año hasta la fecha | 6 Meses | Promedio móvil | 3 Años | 5 Años | |
|---|---|---|---|---|---|
| Volatilidad | 16.89% | 18.21% | 16.13% | 20.32% | 23.24% |
| Índice de Sharpe | 0.27 | 1.69 | 0.40 | 0.10 | 0.25 |
| El mes mejor | +12.11% | +12.11% | +12.11% | +12.11% | +13.15% |
| El mes peor | -5.18% | -5.18% | -5.97% | -9.49% | -9.49% |
| Pérdida máxima | -9.49% | -9.49% | -13.26% | -20.59% | -26.96% |
| Rendimiento superior | -3.12% | - | -0.76% | - | - |
Todas las cotizaciones en EUR
Tramos
| Nombre | Tipo de beneficio | Prec. de rescate | Promedio móvil | 3 Años | |
|---|---|---|---|---|---|
| Candriam Equities L Biotechnolog... | reinvestment | 2,005.2800 | +7.40% | +5.34% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 217.3000 | +9.72% | - | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,010.0900 | +5.01% | -2.02% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,188.1899 | +10.22% | +18.62% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,369.9399 | +7.08% | +15.89% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 353.9900 | +7.59% | +19.68% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 320.4600 | +10.74% | +21.20% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 196.3100 | +3.02% | -3.36% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,795.9900 | +8.08% | +8.09% | |
| Candriam Equities L Biotech.N-H ... | reinvestment | 145.7800 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 584.4100 | +6.48% | +3.36% | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,486.2402 | +7.27% | +4.95% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 192.5500 | +4.61% | -2.32% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 200.6900 | +5.50% | +0.08% | |
| Candriam Equities L Biotech.R US... | reinvestment | 260.3500 | +7.81% | +7.28% | |
| Candriam Equities L Biotechnolo... | reinvestment | 820.1800 | +6.87% | +4.67% | |
| Candriam Equities L Biotechnolog... | paying dividend | 749.0700 | +6.83% | +4.57% |
Performance
| Año hasta la fecha | +2.71% | ||
|---|---|---|---|
| 6 Meses | +15.90% | ||
| Promedio móvil | +10.22% | ||
| 3 Años | +18.62% | ||
| 5 Años | +57.61% | ||
| Desde el principio | +45.88% | ||
| Año | |||
| 2023 | +3.96% | ||
| 2022 | +3.88% | ||
| 2021 | +5.86% | ||
| 2020 | +11.20% | ||
| 2019 | +36.28% | ||
| 2018 | -5.57% | ||
| 2017 | +11.43% | ||
| 2016 | -17.28% | ||
